- NCIt
- C116915
Loading cancer entity…
Loading cancer entity…
Clinical trials
47 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | withdrawn | N/A | 0 | Dana-Farber Cancer InstituteOTHER | 0 | Nov 22, 2024 | clinicaltrials |
| NCT04955938 | A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms | withdrawn | Phase 1 | 0 | University of ChicagoOTHER | 1 | Jul 31, 2024 | clinicaltrials |
| NCT03959046 | GIST in Hematopoietic Stem Cell Transplantation/Bone Marrow Transplantation | withdrawn | N/A | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Feb 15, 2024 | clinicaltrials |
| NCT04390542 | Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy |
Data updated 22 days agoSource updated Nov 22, 2024source: clinicaltrials
| withdrawn |
| N/A |
| 0 |
| Case Comprehensive Cancer CenterOTHER |
| 0 |
| Jul 20, 2021 |
| clinicaltrials |